- Home
- / Ocumension Therapeutics
Ocumension Therapeutics
Stock Price
$5.8
2024-10-29
Market Capitalization
$4.6 B
2024-10-29
Revenue
¥804.4 M
FY, 2025
Ocumension Therapeutics Summary
Company Summary
- Overview
- Ocumension Therapeutics is a provider of ophthalmic pharmaceutical services. It offers drugs and therapies for blepharitis, cataract, glaucoma, ocular hypertension, postoperative inflammation, etc.
- Type
- Public
- Status
- Active
- Founded
- 2017
- Website
- http://www.ocumension.com
- Cybersecurity rating
Table of Contents
Ocumension Therapeutics Financials
Summary Financials
- Revenue (FY, 2025)
- ¥804.4M
- Gross profit (FY, 2025)
- ¥508.7M
- Net income (FY, 2025)
- (¥158.8M)
- Cash (FY, 2025)
- ¥377.5M
- EBIT (FY, 2025)
- (¥162.1M)
- Enterprise value
- $4.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026